会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • DIAGNOSTIC AND MEDICAMENT FOR ANALYSING THE CELL SURFACE PROTEOME OF TUMOUR AND INFLAMMATORY CELLS AND FOR TREATING TUMOROUS AND INFLAMMATORY DISEASES, PREFERABLY USING A SPECIFIC CHEMOKINE RECEPTOR ANALYSIS AND THE CHEMOKINE RECEPTOR-LIGAND INTERACTION
    • 诊断及药物调查肿瘤和炎症细胞的ZELLOBERFLÄCHENPROTEOMS和治疗肿瘤疾病和炎症性疾病优选比趋化因子受体分析与趋化因子受体配体相互作用的帮助
    • WO0172830A3
    • 2002-06-20
    • PCT/EP0103708
    • 2001-04-02
    • IPF PHARMACEUTICALS GMBHFORSSMANN ULFFORSSMANN WOLF-GEORGADERMANN KNUTHEITLAND ALEKSANDRASPODSBERG NIKOLAJ
    • FORSSMANN WOLF-GEORGADERMANN KNUTHEITLAND ALEKSANDRASPODSBERG NIKOLAJ
    • G01N33/53A61K38/00A61K39/395A61K45/00A61P1/00A61P5/00A61P9/00A61P11/00A61P11/06A61P13/00A61P13/12A61P17/00A61P19/02A61P21/00A61P25/00A61P29/00A61P35/00A61P37/02A61P37/06A61P43/00C07K14/52C07K16/28C12P21/08C12Q1/68C07K14/54
    • C07K14/522A61K38/00C07K16/2866
    • The invention relates to the production of a medicament and a diagnostic agent, obtained by a proteome analysis, preferably containing at least two different chemokine receptor ligands or chemokine receptor antibodies and in addition, to the use of at least two different chemokine receptor ligands, chemokine receptor antibodies and/or two different chemokine receptors. The medicament preferably contains as inhibitors, ligands or antibodies of at least two chemokine receptors or of the related algorithms of the surface chemokine receptor proteome. The invention also relates to at least one chemokine receptor ligand and/or a chemokine receptor, peptides and antibodies and to the use of the same for diagnosing and treating tumorous and inflammatory diseases. Similarly, clusters of analysed tumour cell surface proteomes, such as ectoproteases, adhesion molecules or different receptor types can be used. The invention relates to a method for diagnostic and therapeutic purposes and for the medicinal and commercial use of chemokines and their corresponding receptors and their antagonists including antibodies, for inhibiting cancer growth and its metastatic spread and for repressing inflammatory and auto-immune diseases. The method is based on the finding that chemokines act on specific tumour and inflammatory cells in an autocrine, paracrine and endocrine manner by means of the disease-specific constellation of chemokine receptor proteome. Primary and secondary tumours and specific inflammatory cells are controlled in their migration and proliferation behaviour. The diagnostic detection of a local increase in expressed and regulated chemokines and of the presence of the chemokine receptor compositions allows the significant repression or complete prevention of cancer growth, tumour metastatic spread and both inflammatory and auto-immune diseases.
    • 本发明是一种药物的制备,并通过蛋白质组获得的诊断剂,优选含有至少两个不同的趋化因子受体配体或Chemokinrezeptorantikörper,并且进一步使用至少两种不同的趋化因子受体配体,Chemokinrezeptorantikörper和/或两种不同的趋化因子受体。 所述药物含有作为抑制剂优选配体或至少两种趋化因子受体的抗体或表面Chemokinrezeptorproteoms的相关算法和使用至少一种趋化因子受体配体和/或趋化因子受体,肽和抗体的以及它们用于肿瘤性疾病和炎症性疾病的诊断和治疗中的用途 , 以类似的方式簇分析Tumorzelloberflächenproteomen的verwendbar.Die作为Ektoproteasen,粘附分子或各种受体类型的本发明涉及一种用于诊断和治疗的目的以及医学和商业使用趋化因子和它们相应的受体,它们的拮抗剂,包括抗体,癌生长 抑制转移和包括以抑制炎症和自身免疫性疾病。 该方法是基于以下发现,即通过在Chemokinrezeptorproteoms的特定肿瘤和炎症细胞疾病特定星座自分泌,旁分泌和内分泌途径趋化因子的行为。 原发性和继发性肿瘤,以及特定的炎性细胞被控制在它们的迁移和增殖特性。 由所表达的局部增加的和调节的趋化因子的诊断性检测以及趋化因子受体的组合物的存在下产生的肿瘤生长,肿瘤转移和炎症和自身免疫疾病的可能性抑制基本上或完全阻止。